Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02476968
Title To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer (ORZORA)
Acronym ORZORA
Recruitment Completed
Gender female
Phase FDA approved
Variant Requirements Yes
Sponsors AstraZeneca
Age Groups: senior | adult
Covered Countries ITA | GBR | ESP | CAN

Additional content available in CKB BOOST